AbsEn.i
Curation
Istex
Racine
Curation
Checkpoint
Istex
Racine
Istex
Exploration
Accueil
Racine
Racine

Serveur d'exploration Tocilizumab - Curation (Istex)

Index « AbsEn.i » - entrée « tumour »
Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.
tumors < tumour < tumours  Facettes :

List of bibliographic references

Number of relevant bibliographic references: 34.
[0-20] [0 - 20][0 - 34][20-33][20-40]
Ident.Authors (with country if any)Title
000029 (2011) Satoru Shinriki [Japon] ; Hirofumi Jono [Japon] ; Mitsuharu Ueda [Japon] ; Kazutoshi Ota [Japon] ; Tomoko Ota [Japon] ; Takanao Sueyoshi [Japon] ; Yuichi Oike [Japon] ; Mutsuko Ibusuki [Japon] ; Akimitsu Hiraki [Japon] ; Hideki Nakayama [Japon] ; Masanori Shinohara [Japon] ; Yukio Ando [Japon]Interleukin‐6 signalling regulates vascular endothelial growth factor‐C synthesis and lymphangiogenesis in human oral squamous cell carcinoma
000041 (2014) P. Jayasekera [Royaume-Uni] ; R. Parslew [Royaume-Uni] ; A. Al-Sharqi [Royaume-Uni]A case of tumour necrosis factor‐α inhibitor‐ and rituximab‐induced plantar pustular psoriasis that completely resolved with tocilizumab
000057 (2007) Peter Taylor [Royaume-Uni]IL‐6 inhibition in the treatment of rheumatoid arthritis
000122 (2006) C. Christodoulou [Royaume-Uni] ; E. H. Choy [Royaume-Uni]Joint inflammation and cytokine inhibition in rheumatoid arthritis
000194 (2007) M. Schneider [Allemagne]Exploring new territory: considering the future
000211 (2006) Lyndell Lim [États-Unis] ; Eric B. Suhler [États-Unis] ; Justine R. Smith [États-Unis]Biologic therapies for inflammatory eye disease
000251 (2006) Chi Chiu Mok [Hong Kong]Biological therapies for rheumatoid arthritis: beyond TNF‐α blockade
000464 (2009) T. Pap [Allemagne]Aktuelle Trends in Design und Entwicklung monoklonaler Antikörper gegen Entzündungsmediatoren zur Therapie der rheumatoiden Arthritis
000502 (2008) Josef S. Smolen [Autriche] ; Michael E. Weinblatt [États-Unis]When patients with rheumatoid arthritis fail tumour necrosis factor inhibitors: what is the next step?
000520 (2013) C. Carnovale [Italie] ; V. Perrone [Italie] ; C. Borsadoli [Italie] ; A. Mambrini [Italie] ; A. Speziali [Italie] ; G. Froldi [Italie] ; S. Antoniazzi [Italie] ; L. Magistro [Italie] ; E. Clementi [Italie] ; S. Radice [Italie]A case of urinary incontinence by hydroxychloroquine in a geriatric patient
000636 (2013) M. Bodro [Espagne, Australie] ; D. L. Paterson [Australie]Listeriosis in patients receiving biologic therapies
000660 (2013) M. C. Vieira [États-Unis] ; G. Wallenstein ; J. Bradley ; D. Gruben ; T. Koncz [États-Unis] ; S. H. Zwillich ; J. P. Jansen [États-Unis]SAT0115 Tofacitinib Versus Biologic Treatments in Patients with Active Rheumatoid Arthritis Who have had an Inadequate Response to Tumour Necrosis Factor Inhibitors - A Network Meta-Analysis
000713 (2011) M. Korppi [Finlande] ; Me Van Gijn [Pays-Bas] ; K. Antila [Finlande]Hyperimmunoglobulinemia D and periodic fever syndrome in children. Review on therapy with biological drugs and case report
000741 (2013) E. Keystone [Canada] ; S. B. Cohen [États-Unis] ; P. Emery [Royaume-Uni] ; J. M. Kremer [États-Unis] ; M. Dougados [France] ; J. E. Loveless ; C. Chung [États-Unis] ; P. Wong [États-Unis] ; P. B. Lehane [Royaume-Uni] ; H. Tyrrell [Royaume-Uni]AB0526 Sustained efficacy responses and a consistent safety profile with rituximab repeat treatment over 5 years in patients with rheumatoid arthritis and an inadequate response to tumour necrosis factor inhibitors in the reflex study
000912 (2013) L. Puig [Espagne, Canada]Anti‐tumour necrosis factor‐α treatment and weight gain in psoriasis: the ‘pudgy blanching’ conundrum
000943 (2013) C. Codreanu ; I. Ancuta ; R. Ionescu [Roumanie]FRI0220 Sustained clinical efficacy after multiple courses of rituximab in rheumatoid arthritis patients with inadequate response to tumour necrosis factor inhibitors: 2-year data from the repeat (repeated courses in routine clinical practice) study
000A84 (2009) Yutaka Suzuki [Japon] ; Kazuhiko Inoue [Japon] ; Junji Chiba [Japon] ; Yasuo Inoue [Japon] ; Katsuaki Kanbe [Japon]Histological analysis of synovium by treatment of etanercept for rheumatoid arthritis
000A86 (2014) Rajalingham Sakthiswary [Malaisie] ; Syahrul S. Shaharir [Malaisie] ; Mohd S. Mohd Said [Malaisie] ; Abdul W. Asrul [Malaisie] ; Nor S. Shahril [Malaisie]IgA rheumatoid factor as a serological predictor of poor response to tumour necrosis factor α inhibitors in rheumatoid arthritis
000B12 (2014) C. Chabbert [France] ; H. Adamski [France] ; G. Guillet [France] ; B. Sassolas [France] ; L. Misery [France] ; A. Perrinaud [France] ; L. Machet [France] ; G. Quereux [France] ; E. Esteve [France] ; E. Solau-Gervais [France] ; A. Saraux [France] ; E. Polard [France] ; T. Lesimple [France] ; F. Le Gall [France] ; B. Dreno [France] ; A. Dupuy [France]Cutaneous melanoma in patients treated with tumour necrosis factor inhibitors: a retrospective series of 15 patients
000E61 (2011) Cheryl Barnabe [Canada] ; Susan G. Barr [Canada] ; Liam Martin [Canada]Infliximab therapy efficacy and persistence at a Canadian academic centre despite a change in access procedure
000E71 (2008) M. Pierer [Allemagne] ; C. Baerwald [Allemagne]Biologikatherapie bei rheumatologischen Erkrankungen

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Sante/explor/TocilizumabV1/Data/Istex/Curation

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i -k "tumour" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Curation/AbsEn.i  \
                -Sk "tumour" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Curation/biblio.hfd

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Sante
   |area=    TocilizumabV1
   |flux=    Istex
   |étape=   Curation
   |type=    indexItem
   |index=    AbsEn.i
   |clé=    tumour
}}
Wicri

This area was generated with Dilib version V0.6.34.
Data generation: Fri May 22 09:34:00 2020. Site generation: Sun Mar 28 09:01:19 2021